See more : Amalgamated Financial Corp. (AMAL) Income Statement Analysis – Financial Results
Complete financial analysis of Allurion Technologies Inc. (ALUR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Allurion Technologies Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Lonkey Industrial Co.,Ltd.Guangzhou (000523.SZ) Income Statement Analysis – Financial Results
- Alfa Laval AB (publ) (ALFVY) Income Statement Analysis – Financial Results
- Vesync Co., Ltd (2148.HK) Income Statement Analysis – Financial Results
- Odakyu Electric Railway Co., Ltd. (9007.T) Income Statement Analysis – Financial Results
- Kaname Kogyo Co.,Ltd. (6566.T) Income Statement Analysis – Financial Results
Allurion Technologies Inc. (ALUR)
About Allurion Technologies Inc.
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 53.47M | 64.21M | 38.24M | 0.00 |
| Cost of Revenue | 11.97M | 13.49M | 9.05M | 0.00 |
| Gross Profit | 41.50M | 50.73M | 29.19M | 0.00 |
| Gross Profit Ratio | 77.61% | 79.00% | 76.33% | 0.00% |
| Research & Development | 27.69M | 16.97M | 5.73M | 0.00 |
| General & Administrative | 46.02M | 15.37M | 8.82M | 0.00 |
| Selling & Marketing | 46.86M | 50.41M | 27.14M | 0.00 |
| SG&A | 92.88M | 65.77M | 35.96M | 4.56K |
| Other Expenses | 0.00 | -1.15M | -555.00K | -610.00 |
| Operating Expenses | 120.58M | 82.74M | 41.69M | 5.17K |
| Cost & Expenses | 132.55M | 96.22M | 50.74M | 5.17K |
| Interest Income | 0.00 | 10.66M | 49.77K | 0.00 |
| Interest Expense | 10.57M | 4.43M | 3.67M | 0.00 |
| Depreciation & Amortization | 746.00K | 895.00K | 707.00K | 206.30K |
| EBITDA | -69.03M | -32.28M | -12.35M | -5.17K |
| EBITDA Ratio | -129.11% | -48.52% | -32.29% | 0.00% |
| Operating Income | -79.08M | -32.01M | -12.50M | -5.17K |
| Operating Income Ratio | -147.90% | -49.85% | -32.69% | 0.00% |
| Total Other Income/Expenses | -1.27M | -5.59M | 115.00K | 1.00 |
| Income Before Tax | -80.34M | -37.60M | -12.39M | -5.17K |
| Income Before Tax Ratio | -150.27% | -58.56% | -32.39% | 0.00% |
| Income Tax Expense | 264.00K | 143.00K | 3.11M | -206.30K |
| Net Income | -82.30M | -37.74M | -12.39M | -5.17K |
| Net Income Ratio | -153.93% | -58.78% | -32.39% | 0.00% |
| EPS | -2.31 | -1.40 | -0.11 | 0.00 |
| EPS Diluted | -2.31 | -1.40 | -0.11 | 0.00 |
| Weighted Avg Shares Out | 35.58M | 26.92M | 107.81M | 107.81M |
| Weighted Avg Shares Out (Dil) | 35.58M | 26.92M | 107.81M | 107.81M |
Allurion Reports First Quarter 2024 Financial Results and Provides Business Update
NATICK, Mass.--(BUSINESS WIRE)--Allurion Reports First Quarter 2024 Financial Results and Provides Business Update.
Allurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance Survey
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced three oral scientific presentations at the 12th Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders – European Chapter...
Allurion Announces Preliminary First Quarter 2024 Results
NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced preliminary, unaudited results for the first quarter 2024. Management expects preliminary unaudited results for the period as follows: Revenue in the...
Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments
NATICK, Mass.--(BUSINESS WIRE)--Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments.
Why Is Allurion (ALUR) Stock Up 65% Today?
Little-known medical device firm Allurion (NYSE: ALUR ) — which is focused on ending obesity via its swallowable and “procedure-less” intragastric balloon — saw its shares skyrocket on Thursday. Earlier this morning, management announced the commercial availability of its comprehensive...
Allurion Expands Virtual Care Suite to the United States
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the commercial availability of its comprehensive Virtual Care Suite (VCS) in the United States. Already in use by thousands of providers in over...
Allurion Technologies Inc. (ALUR) Q4 2023 Earnings Call Transcript
Allurion Technologies Inc. (ALUR) Q4 2023 Earnings Call Transcript
Allurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
NATICK, Mass.--(BUSINESS WIRE)--Allurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance.
Milena Alberti-Perez Joins Allurion Board of Directors as Audit Committee Chair
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the appointment of its newest board member and Audit Committee Chair, Milena Alberti-Perez, effective as of March 11, 2024. "Milena joins the Allurion...
Brendan Gibbons Appointed Chief Legal Officer at Allurion Technologies
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE:ALUR), a company dedicated to ending obesity, today announced the appointment of Brendan Gibbons as its new Chief Legal Officer and corporate secretary. Brendan joins Allurion with nearly 20 years' experience as a...
Source: https://incomestatements.info
Category: Stock Reports